{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:35:55Z","timestamp":1707525355217},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,29]]},"DOI":"10.7759\/cureus.46226","type":"journal-article","created":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T21:31:13Z","timestamp":1696023073000},"source":"Crossref","is-referenced-by-count":0,"title":["Ceftriaxone-Induced Encephalopathy in a Patient With End-Stage Renal Disease on Hemodialysis"],"prefix":"10.7759","author":[{"given":"Athmananda","family":"Nanjundappa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salina","family":"Munankami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalid","family":"Al Talib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jyotsna","family":"Gummadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumanth Kumar","family":"Bandaru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1875-9114.1985.tb03423.x","article-title":"Ceftriaxone: a beta-lactamase-stable, broad-spectrum cephalosporin with an extended half-life","volume":"5","author":"Beam TR Jr","year":"1985","unstructured":"Beam TR Jr. Ceftriaxone: a beta-lactamase-stable, broad-spectrum cephalosporin with an extended half-life. Pharmacotherapy. 1985, 5:237-53. 10.1002\/j.1875-9114.1985.tb03423.x","journal-title":"Pharmacotherapy"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200645050-00004","article-title":"Population pharmacokinetics of ceftriaxone and pharmacodynamic considerations in haemodialysed patients","volume":"45","author":"Simon N","year":"2006","unstructured":"Simon N, Dussol B, Sampol E, et al.. Population pharmacokinetics of ceftriaxone and pharmacodynamic considerations in haemodialysed patients. Clin Pharmacokinet. 2006, 45:493-501. 10.2165\/00003088-200645050-00004","journal-title":"Clin Pharmacokinet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2019.01.018","article-title":"Serious central nervous system side effects of cephalosporins: a national analysis of serious reports registered in the French Pharmacovigilance Database","volume":"398","author":"Lacroix C","year":"2019","unstructured":"Lacroix C, Kheloufi F, Montastruc F, Bennis Y, Pizzoglio V, Micallef J. Serious central nervous system side effects of cephalosporins: a national analysis of serious reports registered in the French Pharmacovigilance Database. J Neurol Sci. 2019, 398:196-201. 10.1016\/j.jns.2019.01.018","journal-title":"J Neurol Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3109\/00498258709167406","article-title":"Plasma protein binding of ceftriaxone","volume":"17","author":"Popick AC","year":"1987","unstructured":"Popick AC, Crouthamel WG, Bekersky I. Plasma protein binding of ceftriaxone. Xenobiotica. 1987, 17:1139-45. 10.3109\/00498258709167406","journal-title":"Xenobiotica"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo CA","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al.. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981, 30:239-45. 10.1038\/clpt.1981.154","journal-title":"Clin Pharmacol Ther"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2019.06.008","article-title":"Determination of ceftriaxone concentration in human cerebrospinal fluid by high-performance liquid chromatography with UV detection","volume":"1124","author":"Kotani A","year":"2019","unstructured":"Kotani A, Hirai J, Hamada Y, Fujita J, Hakamata H. Determination of ceftriaxone concentration in human cerebrospinal fluid by high-performance liquid chromatography with UV detection. J Chromatogr B Analyt Technol Biomed Life Sci. 2019, 1124:161-4. 10.1016\/j.jchromb.2019.06.008","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2022.01.023","article-title":"Ceftriaxone-associated encephalopathy in a patient with high levels of ceftriaxone in blood and cerebrospinal fluid","volume":"116","author":"Nishioka H","year":"2022","unstructured":"Nishioka H, Cho Y, Irie K, Kanamori M. Ceftriaxone-associated encephalopathy in a patient with high levels of ceftriaxone in blood and cerebrospinal fluid. Int J Infect Dis. 2022, 116:223-5. 10.1016\/j.ijid.2022.01.023","journal-title":"Int J Infect Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.25.4.438","article-title":"Ceftriaxone pharmacokinetics in patients with various degrees of renal impairment","volume":"25","author":"Patel IH","year":"1984","unstructured":"Patel IH, Sugihara JG, Weinfeld RE, Wong EG, Siemsen AW, Berman SJ. Ceftriaxone pharmacokinetics in patients with various degrees of renal impairment. Antimicrob Agents Chemother. 1984, 25:438-42. 10.1128\/AAC.25.4.438","journal-title":"Antimicrob Agents Chemother"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002455","article-title":"Antibiotic-associated encephalopathy","volume":"86","author":"Bhattacharyya S","year":"2016","unstructured":"Bhattacharyya S, Darby RR, Raibagkar P, Gonzalez Castro LN, Berkowitz AL. Antibiotic-associated encephalopathy. Neurology. 2016, 86:963-71. 10.1212\/WNL.0000000000002455","journal-title":"Neurology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2008.462","article-title":"Use of hemodialysis and hemoperfusion in poisoned patients","volume":"74","author":"Holubek WJ","year":"2008","unstructured":"Holubek WJ, Hoffman RS, Goldfarb DS, Nelson LS. Use of hemodialysis and hemoperfusion in poisoned patients. Kidney Int. 2008, 74:1327-34. 10.1038\/ki.2008.462","journal-title":"Kidney Int"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.1785-18","article-title":"Encephalopathy induced by high plasma and cerebrospinal fluid ceftriaxone concentrations in a hemodialysis patient","volume":"58","author":"Suzuki S","year":"2019","unstructured":"Suzuki S, Naito S, Numasawa Y, et al.. Encephalopathy induced by high plasma and cerebrospinal fluid ceftriaxone concentrations in a hemodialysis patient. Intern Med. 2019, 58:1775-9. 10.2169\/internalmedicine.1785-18","journal-title":"Intern Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/hdi.13018","article-title":"Two cases of ceftriaxone-induced encephalopathy treated by hemoperfusion in hemodialysis patients","volume":"26","author":"Onogi C","year":"2022","unstructured":"Onogi C, Osada A, Imai K, et al.. Two cases of ceftriaxone-induced encephalopathy treated by hemoperfusion in hemodialysis patients. Hemodial Int. 2022, 26:E27-30. 10.1111\/hdi.13018","journal-title":"Hemodial Int"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/187906-ceftriaxone-induced-encephalopathy-in-a-patient-with-end-stage-renal-disease-on-hemodialysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:09:04Z","timestamp":1707509344000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/187906-ceftriaxone-induced-encephalopathy-in-a-patient-with-end-stage-renal-disease-on-hemodialysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,29]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.46226","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,29]]}}}